Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
申请人:The Broad Institute, Inc.
公开号:US10793538B2
公开(公告)日:2020-10-06
The present invention provides compounds of formula (I):
or a pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein W, X, n, s, t, and Ra are as described herein. The present invention relates generally to selective inhibitors of histone deacetylase and to methods of making and using them.
本发明提供了式 (I) 的化合物:
或其药学上可接受的盐、溶液或原药,其中 W、X、n、s、t 和 Ra 如本文所述。本发明一般涉及组蛋白去乙酰化酶的选择性抑制剂及其制造和使用方法。
US9914717B2
申请人:——
公开号:US9914717B2
公开(公告)日:2018-03-13
[EN] CYCLOALKENYL HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS<br/>[FR] DÉRIVÉS D'ACIDE HYDROXAMIQUE CYCLOALCÉNYLE ET LEURS UTILISATIONS EN TANT QU'INHIBITEURS DE L'HISTONE DÉSACÉTYLASE
申请人:BROAD INST INC
公开号:WO2014100438A1
公开(公告)日:2014-06-26
The present invention provides compounds of formula (I) or a pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein W, X, n, s, t, and Ra are as described herein. The present invention relates generally to selective inhibitors of histone deacetylase and to methods of making and using them.
CYCLOALKENYL HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS
申请人:THE BOARD INSTITUTE, INC.
公开号:US20150368221A1
公开(公告)日:2015-12-24
The present invention provides compounds of formula (I) or a pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein W, X, n, s, t, and Ra are as described herein. The present invention relates generally to selective inhibitors of histone deacetylase and to methods of making and using them.